Stacey A Fedewa1, K Robin Yabroff2, Robert A Smith3, Ann Goding Sauer2, Xuesong Han2, Ahmedin Jemal2. 1. Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia. Electronic address: stacey.fedewa@cancer.org. 2. Surveillance and Health Services Research, American Cancer Society, Atlanta, Georgia. 3. Cancer Control Sciences, American Cancer Society, Atlanta, Georgia.
Abstract
INTRODUCTION: Medicaid expansions following the Affordable Care Act have improved insurance coverage in low-income adults, but little is known about its impact on cancer screening. This study examined associations between Medicaid expansion timing and colorectal cancer (CRC) and breast cancer (BC) screening. METHODS: Up-to-date and past 2-year CRC (n=95,400) and BC (women, n=43,279) screening prevalence were computed among low-income respondents aged 50-64 years in 2012, 2014, and 2016 Behavioral Risk Factor Surveillance System data. Respondents were grouped according to Medicaid expansion timing as: very early ([VE] six states expanding March 1, 2010-April 14, 2011), early (21 states expanding January 1, 2014-August 15, 2014), late (five states expanding January 1, 2015-July 1, 2016), and non-expansion states (19 states). Absolute adjusted difference-in-differences (aDDs) were computed in 2018-2019 (ref, non-expansion states). RESULTS: Between 2012 and 2016, absolute up-to-date CRC screening increased by 8.8%, 2.9%, 2.4%, and 3.8% among low-income adults in VE, early, late, and non-expansion states, respectively. Past 2-year CRC screening increased by 8.0% in VE and 2.8% in non-expansion states, with an aDD of 4.9% (p=0.041). In 2012-2016, up-to-date BC screening increased by 5.1%, 4.9%, and 3.7% among low-income women in VE, early, and non-expansion states, respectively, but aDDs were not statistically significant. CONCLUSIONS: Prevalence of CRC and BC screening among low-income adults rose in Medicaid expansion states, though increases were significantly higher than those in non-expansion states only for recent CRC screening in VE expansion states. Large-scale improvements in cancer screening may take several years following expansion in access to care.
INTRODUCTION: Medicaid expansions following the Affordable Care Act have improved insurance coverage in low-income adults, but little is known about its impact on cancer screening. This study examined associations between Medicaid expansion timing and colorectal cancer (CRC) and breast cancer (BC) screening. METHODS: Up-to-date and past 2-year CRC (n=95,400) and BC (women, n=43,279) screening prevalence were computed among low-income respondents aged 50-64 years in 2012, 2014, and 2016 Behavioral Risk Factor Surveillance System data. Respondents were grouped according to Medicaid expansion timing as: very early ([VE] six states expanding March 1, 2010-April 14, 2011), early (21 states expanding January 1, 2014-August 15, 2014), late (five states expanding January 1, 2015-July 1, 2016), and non-expansion states (19 states). Absolute adjusted difference-in-differences (aDDs) were computed in 2018-2019 (ref, non-expansion states). RESULTS: Between 2012 and 2016, absolute up-to-date CRC screening increased by 8.8%, 2.9%, 2.4%, and 3.8% among low-income adults in VE, early, late, and non-expansion states, respectively. Past 2-year CRC screening increased by 8.0% in VE and 2.8% in non-expansion states, with an aDD of 4.9% (p=0.041). In 2012-2016, up-to-date BC screening increased by 5.1%, 4.9%, and 3.7% among low-income women in VE, early, and non-expansion states, respectively, but aDDs were not statistically significant. CONCLUSIONS: Prevalence of CRC and BC screening among low-income adults rose in Medicaid expansion states, though increases were significantly higher than those in non-expansion states only for recent CRC screening in VE expansion states. Large-scale improvements in cancer screening may take several years following expansion in access to care.
Authors: David A Barrington; Jennifer A Sinnott; Corinne Calo; David E Cohn; Casey M Cosgrove; Ashley S Felix Journal: Gynecol Oncol Date: 2020-06-09 Impact factor: 5.482
Authors: Michelle R Xu; Amanda M B Kelly; Lawrence H Kushi; Mary E Reed; Howard K Koh; Donna Spiegelman Journal: Am J Prev Med Date: 2020-01-31 Impact factor: 5.043
Authors: Daniel B Nelson; Benjamin D Sommers; Phillip M Singer; Emily K Arntson; Renuka Tipirneni Journal: J Gen Intern Med Date: 2020-04-01 Impact factor: 5.128
Authors: Betsy C Risendal; James R Hébert; Elaine H Morrato; Cynthia A Thomson; Cam N Escoffery; Daniela B Friedman; Andrea J Dwyer; Linda S Overholser; Stephanie B Wheeler Journal: Am J Prev Med Date: 2021-02-23 Impact factor: 5.043
Authors: Neal G Spada; Emily M Geramita; Maryam Zamanian; G J van Londen; Zhaojun Sun; Lindsay M Sabik Journal: J Womens Health (Larchmt) Date: 2020-09-28 Impact factor: 2.681
Authors: Justin M Barnes; Kimberly J Johnson; Eric Adjei Boakye; Lidia Schapira; Tomi Akinyemiju; Eliza M Park; Evan M Graboyes; Nosayaba Osazuwa-Peters Journal: J Natl Cancer Inst Date: 2021-07-14 Impact factor: 11.816